268 related articles for article (PubMed ID: 23844757)
1. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits.
Patane MA; Schubert W; Sanford T; Gee R; Burgos M; Isom WP; Ruiz-Perez B
J Ocul Pharmacol Ther; 2013 Oct; 29(8):760-9. PubMed ID: 23844757
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.
Cohen AE; Assang C; Patane MA; From S; Korenfeld M;
Ophthalmology; 2012 Jan; 119(1):66-73. PubMed ID: 22115712
[TBL] [Abstract][Full Text] [Related]
3. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel.
Eljarrat-Binstock E; Raiskup F; Frucht-Pery J; Domb AJ
J Control Release; 2005 Sep; 106(3):386-90. PubMed ID: 16026884
[TBL] [Abstract][Full Text] [Related]
4. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
5. [Transcorneal and transscleral iontophoresis of the dexamethasone phosphate into the rabbit eye].
Raiskup-Wolf F; Eljarrat-Binstock E; Rehák M; Domb A; Frucht-Pery J
Cesk Slov Oftalmol; 2007 Sep; 63(5):360-8. PubMed ID: 17915587
[TBL] [Abstract][Full Text] [Related]
6. Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
Sheppard J; Garg S; Lievens C; Brandano L; Wirostko B; Korenfeld M; Raizman M; Foster CS
Am J Ophthalmol; 2020 Mar; 211():76-86. PubMed ID: 31726034
[TBL] [Abstract][Full Text] [Related]
7. Ocular Drug Distribution and Safety of a Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in Rabbit.
Papangkorn K; Higuchi JW; Brar B; Higuchi WI
J Ocul Pharmacol Ther; 2018 May; 34(4):325-334. PubMed ID: 29432054
[TBL] [Abstract][Full Text] [Related]
8. Iontophoresis of dexamethosone-phosphate into the equine tibiotarsal joint.
Blackford J; Doherty TJ; Ferslew KE; Panus PC
J Vet Pharmacol Ther; 2000 Aug; 23(4):229-36. PubMed ID: 11106997
[TBL] [Abstract][Full Text] [Related]
9. Failure to detect dexamethasone phosphate in the local venous blood postcathodic lontophoresis in humans.
Smutok MA; Mayo MF; Gabaree CL; Ferslew KE; Panus PC
J Orthop Sports Phys Ther; 2002 Sep; 32(9):461-8. PubMed ID: 12322812
[TBL] [Abstract][Full Text] [Related]
10. Transscleral iontophoresis of dexamethasone.
Lam TT; Edward DP; Zhu XA; Tso MO
Arch Ophthalmol; 1989 Sep; 107(9):1368-71. PubMed ID: 2783069
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic Drug Delivery Using Iontophoresis: Recent Clinical Applications.
Perez VL; Wirostko B; Korenfeld M; From S; Raizman M
J Ocul Pharmacol Ther; 2020 Mar; 36(2):75-87. PubMed ID: 31755807
[No Abstract] [Full Text] [Related]
12. The time course of dexamethasone delivery using iontophoresis through human skin, measured via microdialysis.
Rigby JH; Draper DO; Johnson AW; Myrer JW; Eggett DL; Mack GW
J Orthop Sports Phys Ther; 2015 Mar; 45(3):190-7. PubMed ID: 25679344
[TBL] [Abstract][Full Text] [Related]
13. Short-term ocular toxicity and eye irritation tests following application of sufentanil in rabbits.
Chen H; Chen Z; Xu Y
Eye Sci; 2014 Dec; 29(4):193-7. PubMed ID: 26016069
[TBL] [Abstract][Full Text] [Related]
14. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
15. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
Shafiee A; Bucolo C; Budzynski E; Ward KW; López FJ
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1422-30. PubMed ID: 20881303
[TBL] [Abstract][Full Text] [Related]
16. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
Pan Q; Xu Q; Boylan NJ; Lamb NW; Emmert DG; Yang JC; Tang L; Heflin T; Alwadani S; Eberhart CG; Stark WJ; Hanes J
J Control Release; 2015 Mar; 201():32-40. PubMed ID: 25576786
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Ocular Drug Delivery System of Dexamethasone Sodium Phosphate in the Treatment of Experimental Uveitis Rabbit.
Papangkorn K; Prendergast E; Higuchi JW; Brar B; Higuchi WI
J Ocul Pharmacol Ther; 2017 Dec; 33(10):753-762. PubMed ID: 29022761
[TBL] [Abstract][Full Text] [Related]
19. Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial.
Papangkorn K; Truett KR; Vitale AT; Jhaveri C; Scales DK; Foster CS; Montieth A; Higuchi JW; Brar B; Higuchi WI
Curr Eye Res; 2019 Feb; 44(2):185-193. PubMed ID: 30354530
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis.
Li SK; Jeong EK; Hastings MS
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1224-31. PubMed ID: 15037591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
